Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
December 19, 2018
Equillium Granted U.S. FDA Fast Track Designation for EQ001 for the Treatment of Acute Graft-Versus-Host Disease
LA JOLLA, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Equillium, Inc. (EQ), a biotechnology company developing treatments for severe immuno-inflammatory disorders, today announced that the ...
December 19, 2018
Arena Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 10
SAN DIEGO, Dec. 19, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, will ...
December 19, 2018
InflaRx Receives European Approval to Initiate Phase II Clinical Trial with IFX-1 in ANCA-Associated Vasculitis
JENA, Germany, Dec. 19, 2018 (GLOBE NEWSWIRE) -- InflaRx N.V. (IFRX), a biopharmaceutical company developing innovative therapeutics to treat devastating inflammatory diseases by targeting the ...
December 19, 2018
Eyenovia Prices Public Offering of Common Stock
NEW YORK, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (“Eyenovia” or the “Company”) (EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of ...
December 19, 2018
MannKind Announces Commencement of Public Offering
WESTLAKE VILLAGE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) (MannKind) today announced that it has commenced an underwritten public offering to issue ...
December 19, 2018
Soleno Therapeutics Announces $16.5 Million Private Placement
REDWOOD CITY, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
December 19, 2018
Inspire Medical Systems, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference
MINNEAPOLIS, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative ...
December 19, 2018
FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)
COPENHAGEN, Denmark, Dec. 19, 2018 /PRNewswire/ -- Veloxis Pharmaceuticals announced today that the U.S. Food & Drug Administration (FDA) approved a new indication for Envarsus XR ...
December 19, 2018
ADMA Biologics Provides Regulatory Update on BIVIGAM® PAS Submissions
RAMSEY, N.J. and BOCA RATON, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical ...
December 17, 2018
Saniona’s tesofensine meets primary and secondary endpoints in Phase 3 obesity registration trial
Saniona (SANION.ST), a biotech company focused on CNS and eating disorders, today announced statistically and clinically significant weight loss for both doses of tesofensine compared ...
December 17, 2018
DURECT Corporation Announces Retirement of Dr. Felix Theeuwes as Chairman of the Board and Distinguished Scientist
CUPERTINO, Calif., Dec. 17, 2018 /PRNewswire/ -- DURECT Corporation (DRRX) announced today that Felix Theeuwes will retire as Chairman of the Board and Distinguished Scientist effective ...
December 17, 2018
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib for Treatment of Hepatitis Delta Virus (HDV) Infection
PALO ALTO, Calif., Dec. 17, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, ...
December 17, 2018
Arena Pharmaceuticals Appoints Experienced Life Sciences Industry Finance Executive Manmeet S. Soni to Board of Directors
SAN DIEGO, Dec. 17, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced the appointment of Manmeet S. Soni as a non-executive director. Mr. Soni is a highly ...
December 17, 2018
Acer Therapeutics Appoints Salma Jutt as Chief Commercial Officer
NEWTON, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
December 17, 2018
ProQR Announces Publication in Nature Medicine of QR-110 Data for Leber’s Congenital Amaurosis 10
LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of ...
December 17, 2018
OSE Immunotherapeutics Appoints Julien Perrier Chief Commercial Officer
NANTES, France, Dec. 17, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA(ISIN: FR0012127173; Mnémo: OSE) today announced the appointment of Julien Perrier as chief commercial officer. ...
December 17, 2018
Transgene Announces Financial Calendar for 2019
STRASBOURG, France--(BUSINESS WIRE)-- Regulatory News: Transgene (TNG.PA) today announced its financial reporting dates for 2019: March 20: 2018 Fiscal Year Results May 13:  First Quarter ...
December 11, 2018
BioLineRx Announces Initiation of Triple Combination Arm of Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Under Immuno-Oncology Collaboration
TEL AVIV, Israel, Dec. 11, 2018 /PRNewswire/ -- BioLineRx Ltd. (BLRX) (BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today the initiation ...
December 11, 2018
Entera Bio and Amgen Enter Strategic Research Collaboration in Inflammatory Disease and Other Serious Illnesses
JERUSALEM, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (ENTX) announced today that it has entered into a research collaboration and license agreement with ...
December 11, 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer™ as Published in JACC
VANCOUVER, Dec. 11, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN)(NVCN.TO), a leader in the development of minimally invasive transcatheter mitral valve replacement ...
Page 21 of 138